Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder TrialNews DeskJuly 28, 20260 GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies…